The New York University (NYU) Seminars in Gastroenterology have been developed to examine some of the most recent trends, issues, and controversies in the field, for the advancement of practicing gastroenterologists.

Clinician understanding of the genetic basis for hereditary colorectal cancer syndromes is improving, but with this comes additional issues. A predisposition to other secondary malignancies is being recognized. Revised guidelines from the National Cancer Institute may provide a way to overcome the challenge of identifying patients at risk, and for further selection of patients for genetic testing. Data from studies such as the National Polyp Study may offer some guidance on patient screening, monitoring, and surveillance.

With the growing epidemics of obesity and diabetes, understanding the role of visceral fat and inflammation in disease states, including fatty liver disease, is key. It is anticipated that fatty liver disease will be a frequent problem and a challenge for hepatologists in the future. A better understanding of disease mechanisms may help to guide treatment and patient management. Also in the liver, there is an increased urgency to identify and treat chronic hepatitis C earlier, to minimize the complications resulting from disease, including hepatocellular cancer. Alternative treatment strategies are needed for nonresponders to pegylated interferon, ribavirin and other difficult-to-treat populations.

Also on the forefront of gastroenterology are new applications for existing technology, including endoscopy, with uses evolving in neuro-oncology, transgastric surgery, and anti-reflux surgery and anti-reflux procedures. With the mechanisms of inflammatory disease being further elucidated over the past several years, newer treatment strategies for inflammatory bowel disease are emerging, including biologic therapy, probiotics and dietary approaches, among others.

Download Brochure...

Comprehensive Gynecology
A Clinical Update for the Practicing Physician
This course has been developed by nationally recognized authorities in the field of gynecology to provide an annual review of new developments for the physician who attends the female patient. As authors of the highly regarded Comprehensive Gynecology textbook, Drs. Herbst, Mishell and Stenchever bring their unique expertise to a practical, clincally applicable format. The course is structured to provide attendees with ample opportunity for one-on-one discussion with faculty and colleagues.

Clinical Infectious Disease
Fifth Annual Management Review for the Practicing Physician
This course is designed to provide an update in important areas, utilizing a faculty of nationally recognized experts who can communicate practical advice to clinicians. Special case history sessions will afford attendees the opportunity to learn from practical application of theories and therapeutic techniques, as well as a chance to interface with faculty and peers.

Clinical Infectious Disease
Sinusitis: Current Management
A Free CME lunch and learn to begin immediately following the morning plenary session of Clinical Infectious Disease.

Fourth Annual Palm Beach Cancer Symposium: Moving Beyond the Ordinary
Sponsored by the CME Committee of the Boca Raton Community Hospital, this 2-day course is designed for medical, radiation and surgical oncologists; gynecologic oncologists; pulmonologists; gastroenterologists, urologists; primary care physicians; fellows/residents pursuing careers in oncology; and oncology nurses. The curriculum is intended to provide an overview of the current advances in the treatment of cancer, including the latest strategies in cancer therapies and the future impact of these therapies on improving survival rates and quality of life. Our nationally recognized faculty will discuss topics such as biological therapies for breast cancer, efficacy plateaus in non small cell lung cancer, cytoprotective agents for head and neck cancer, designer drugs for lymphoproliferative disorders, current status of vaccine therapy, targeted therapies for myeloma, systemic therapy for genitourinary tumors, molecular therapy for colorectal cancer, treatment of chronic myelogenous leukemia, advances in radiation oncology, and genetic counseling for hereditary cancers.

Pediatric Critical Care Medicine
This course has been organized to provide a comprehensive update in the diagnosis, monitoring, and management of the critically ill pediatric patient and to provide preparation for the Pediatric Critical Care subspecialty examination of the American Board of Pediatrics (ABP).

Dermatology Issues In the Primary Care Setting
This course is intended to help improve diagnosis and treatment skills for primary care practitioners, as they are routinely called upon to make accurate and timely diagnoses of skin diseases in order to either treat patients or refer them to a dermatologist. Topics that will be covered include drug-related eruptions, melanoma and nonmelanoma skin cancer, topical dermatology products, and common surgical procedures and nonsurgical alternatives.

Critical Care Medicine
Annual Update and Board Review
This course has been organized to provide a comprehensive update in the diagnosis, monitoring, and management of the critically ill patient and to provide preparation for the critical care subspecialty examination of the American Board of Internal Medicine.

Critical Care Medicine
Cutting Edge Therapies for Sepsis
A free CME Satellite symposium which will be held immediately following the afternoon session of the Critical Care Medicine 2002 course.

Management of VRE and MRSA
Current Therapies and Future Trends
A free CME Satellite symposium which will be held immediately following the afternoon session of the Critical Care Medicine 2002 course.

Third Annual Palm Beach Cancer Symposium: Filling in the Gaps
Sponsored by the CME Committee of the Boca Raton Community Hospital, this 2-day course is designed for medical, radiation, and surgical oncologists; pulmonologists; gastroenterologists; urologists; primary care physicians; fellows/residents pursuing careers in oncology; and oncology nurses. The curriculum is intended to provide participants with an overview of the effects on cancer, management techniques, and current treatment methodologies in order to give physicians the tools to provide optimal care. Our nationally recognized faculty will discuss topics such as pain management; diet; telemedicine; antiangiogenesis; lymphoma treatment; implications of the human genome on cancer care; elevated PSA levels; cancer screening in primary care practices; management, treatment, and genetic counseling for breast cancer; complementary, alternative, and multimodality therapies; and talking to patients about a cancer diagnosis. Meet the Professor sessions enhance the educational value of this course.

Angiotensin II and Vascular Disease
A Link Between Endothelial Dysfunction, Atherosclerosis, and Hypertension?
This symposium will reveal the details of one of the largest and most ambitious clinical trials designed to investigate the role of an angiotensin II receptor blocker (ARB), an angiotensin converting enzyme (ACE) inhibitor, and a combination of the two in the prevention of stroke, myocardial infarction, and cardiovascular death. Both ARBs and ACE inhibitors are known to reduce blood pressure through interruption of the renin-angiotensin system. The Heart Outcomes Prevention Evaluation (HOPE) study has recently shown that the ACE inhibitor ramipril reduced the risk of a primary cardiovascular event in high-risk patients by 22%. The ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) study described in this symposium will evaluate the value of the ARB telmisartan for the prevention of cardiovascular morbidity and mortality in comparison to, and in combination with, ramipril. This 5-year outcome study will enroll approximately 30,000 patients in 35 countries. The esteemed symposium faculty will also discuss the proposed mechanisms by which 24-hour blood pressure patterns and agents that affect the renin-angiotensin system impact cardiovascular morbidity and mortality.

Emerging Strategies Using Combination Therapy to Achieve Target Blood Pressure: A Focus in High-Risk Populations
This symposium highlights the need for aggressive treatment of hypertension as a means to bring patients to the target blood pressure values set by the JNC VI and other consensus groups. Epidemiologic surveys such as the NHANES III show that only a minority of hypertensive patients have acceptable blood pressure control rates. Combination therapy is emerging as an attractive means to achieve improved blood pressure control in these difficult-to-treat patient groups. The purpose of this symposium is to review the variety of combination agents available for the treatment of hypertension and to discuss the treatment strategies needed to control blood pressure in high-risk hypertensive populations. The information conveyed in this symposium is intended to result in enhanced patient care that will help to improve the statistics on control of blood pressure.

Resistant Bacterial Pathogens in the Year 2000:
Epidemiology, Strategies for Prevention, and Therapy of Highly Resistant Pathogens - A Management Review for the Practicing Physician
A Free CME satellite symposium which will be held be held immediately following the morning plenary session of Clinical Infectious Disease 2001: A Management Review for the Practicing Physician.

Cancer Therapy for the New Millennium
Mainstream, Complementary, and Alternative Care
Endorsed by the Memorial Sloan-Kettering Cancer Center, the International Union Against Cancer (UICC), and The Amazon Project, this 3-day conference reviews both mainstream and alternative/complementary cancer care. The program faculty includes world-renowned specialists Gianni Bonadonna, MD, Paul P. Carbone, MD, Barrie R. Cassileth, PhD, Lucio Luzzato, MD, Eliezer Robinson, MD, and Umberto Veronesi, MD. In appreciation of the unique culture of the host city, some events will be held in historic ruins and ancient buildings.

Frontiers in Reproduction Symposium
The Oocyte and Human Reproduction
Sponsored by the National Institute of Child Health and Human Development and the National Institute of Environmental Health Sciences, both of the National Institutes of Health, this symposium is geared toward physicians, residents, scientists, and students in the field of reproductive technology. Current knowledge and future research into the role of oocytes and eggs in human repoduction; the development of germ cells to mature eggs; new technologies in human fertility and contraception; and ethical issues raised by reproductive technologies will be discussed. The symposium includes a poster session for unpublished work.

Advancing the Practice of Oncology: Discovering the Role of Cyclooxygenase-2 Inhibition
A CME satellite symposium preceding the American Society of Clinical Oncology (ASCO) 36th Annual Meeting
This symposium will review the science of cyclooxygenases-1 and -2 (COX-1, COX-2) as it relates to oncology. The role of COX-2 overexpression and its implications will be discussed. Preclinical and clinical data will be reviewed to help interpret the relevance of COX-2 inhibition. Finally, the faculty will convene a panel discussion to explore the potential future applications of COX-2 inhibitors.

Diagnosis and Management of Urinary Problems and Other Pelvic Floor Disorders In Women: An Authoritative Clinical Update on the Latest in Diagnostic and Management Techniques for Female Urinary Incontinence and Pelvic Floor Dysfunction
This course is designed to present a comprehensive review of the function of the pelvic floor in women, the pathologic syndromes derived from its dysfunction, and diagnostic and management strategies for dealing with pelvic floor disorders. Special emphasis will be made on "in-office" evaluation and management in a primary care office setting. In addition, clinical algorithms and indications for referrals will be discussed.

Management of Serious Infections due to Drug-Resistant, Gram-Positive Cocci
A CME Satellite Symposium to the Clinical Infectious Disease 2000 Course
This symposium will cover the dosing, administration, adverse events, and drug interactions of the newer antibiotics used in the treatment of; the therapeutic options for; and the epidemiology and mechanisms of resistance of drug-resistant, gram-positive cocci.

back to top

<< Back to CBC List of Meetings and Symposia

Privacy Policy | Terms Of Use